Nikolopoulos Markos, Karampela Irene, Antonakos Georgios, Tzortzis Evangelos, Stratigou Theodora, Diomidous Marianna, Dalamaga Maria
Information Technology & Telecommunication Department, IPTO S.A., Greece.
Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Stud Health Technol Inform. 2019 Jul 4;262:39-42. doi: 10.3233/SHTI190011.
Gestational Diabetes Mellitus (GDM) has been associated with a plethora of maternal and neonatal comorbidities as well as adverse pregnancy outcomes. Evidence supports that identifying women with GDM and tight controlling of blood glucose (BG) levels are the fundamental steps for an effective management and prevention of risks associated with GDM. Recent advances in mobile phone applications have shown that they may offer personalized health care services, improve patient's care, independence and self-management as well as enhance patient's compliance to BG monitoring and treatment. Our aim was to identify and appraise main mobile phone applications that were evaluated by published clinical studies. Therefore, mobile applications that were accepted and deployed by healthcare providers, mainly hospitals, such as MobiGuide (Spain), Pregnant+ (Norway) and GDm-Health (UK) were reviewed herein.
妊娠期糖尿病（GDM）与大量孕产妇和新生儿合并症以及不良妊娠结局相关。有证据支持，识别患有GDM的女性并严格控制血糖（BG）水平是有效管理和预防与GDM相关风险的基本步骤。手机应用程序的最新进展表明，它们可以提供个性化医疗服务，改善患者护理、自主性和自我管理，以及提高患者对BG监测和治疗的依从性。我们的目的是识别和评估已发表临床研究评估过的主要手机应用程序。因此，本文对主要由医疗保健提供者（主要是医院）接受和部署的手机应用程序进行了综述，如MobiGuide（西班牙）、Pregnant+（挪威）和GDm-Health（英国）。
